A new game changing treatment for people with multiple myeloma will now be available on the NHS in E...
Read moreConclusion: Blincyto has significant clinical benefits, but that further evidence on cost-effective...
Read moreNHS England continues to develop its pricing and reimbursement expertise by appointing Blake Dark, a...
Read moreIf the French government is able to deliver, pharmaceutical companies can look forward to potentiall...
Read moreDetermine the potential price and reimbursement status of a prospective business development asset.
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for an oncol...
Read moreSupporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.
Read moreEnabled a biotech to achieve its targets by provision of expert pricing support during a company res...
Read moreOur client wanted to develop a n e-learning training programme to enhance the market access capabili...
Read moreReview of secondary literature and clinical trial databases to understand payer willingness to pay.
Read more